Literature DB >> 26566937

Responses of dural mast cells in concussive and blast models of mild traumatic brain injury in mice: Potential implications for post-traumatic headache.

Dan Levy1, Shahaf Edut2, Renana Baraz-Goldstein2, Vardit Rubovitch2, Ruth Defrin3, Dara Bree4, Helaine Gariepy4, Jun Zhao5, Chaim G Pick6.   

Abstract

BACKGROUND: Chronic post-traumatic headache (PTH) is one of the most common symptoms of mild traumatic brain injury (mTBI) but its underlying mechanisms remain unknown. Inflammatory degranulation of dural mast cells (MCs) is thought to promote headache, and may play a role in PTH. Whether mTBI is associated with persistent degranulation of dural MCs is yet to be determined.
METHODS: Histochemistry was used to evaluate time course changes in dural MC density and degranulation level in concussive head trauma and blast mouse models of mTBI. The effects of sumatriptan and the MC stabilizer cromolyn sodium on concussion-evoked dural MC degranulation were also investigated.
RESULTS: Concussive head injury evoked persistent MC degranulation for at least 30 days. Blast trauma gave rise to a delayed MC degranulation response commencing at seven days that also persisted for at least 30 days. Neither sumatriptan nor cromolyn treatment reduced concussion-evoked persistent MC degranulation.
CONCLUSIONS: mTBI evoked by closed head injury or blast exposure is associated with persistent dural MC degranulation. Such a response in mTBI patients may contribute to PTH. Amelioration of PTH by sumatriptan may not involve inhibition of dural MC degranulation. If persistent dural MC degranulation contributes to PTH, then cromolyn treatment may not be effective. © International Headache Society 2015.

Entities:  

Keywords:  Minimal traumatic brain injury; blast; concussion; dura; mast cell; mouse; posttraumatic headache

Mesh:

Year:  2015        PMID: 26566937      PMCID: PMC5500910          DOI: 10.1177/0333102415617412

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  33 in total

1.  Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1.

Authors:  A Ericsson; C Arias; P E Sawchenko
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  A mouse model of blast-induced mild traumatic brain injury.

Authors:  Vardit Rubovitch; Meital Ten-Bosch; Ofer Zohar; Catherine R Harrison; Catherine Tempel-Brami; Elliot Stein; Barry J Hoffer; Carey D Balaban; Shaul Schreiber; Wen-Ta Chiu; Chaim G Pick
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

3.  A rat model of changes in dural mast cells and brain histamine receptor H3 expression following traumatic brain injury.

Authors:  Ryo Shimada; Ken-Ichiro Nakao; Rui Furutani; Kazuhiko Kibayashi
Journal:  J Clin Neurosci       Date:  2012-01-25       Impact factor: 1.961

4.  Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice.

Authors:  Martha E Stokely; Edward L Orr
Journal:  J Neurotrauma       Date:  2008-01       Impact factor: 5.269

5.  Spreading depression triggers headache by activating neuronal Panx1 channels.

Authors:  Hulya Karatas; Sefik Evren Erdener; Yasemin Gursoy-Ozdemir; Sevda Lule; Emine Eren-Koçak; Zümrüt Duygu Sen; Turgay Dalkara
Journal:  Science       Date:  2013-03-01       Impact factor: 47.728

Review 6.  Origin of pain in migraine: evidence for peripheral sensitisation.

Authors:  Jes Olesen; Rami Burstein; Messoud Ashina; Peer Tfelt-Hansen
Journal:  Lancet Neurol       Date:  2009-07       Impact factor: 44.182

7.  Medication usage patterns for headache treatment after mild traumatic brain injury.

Authors:  Craig DiTommaso; Jeanne M Hoffman; Sylvia Lucas; Sureyya Dikmen; Nancy Temkin; Kathleen R Bell
Journal:  Headache       Date:  2014-03       Impact factor: 5.887

8.  5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation.

Authors:  M G Buzzi; V Dimitriadou; T C Theoharides; M A Moskowitz
Journal:  Brain Res       Date:  1992-06-26       Impact factor: 3.252

9.  Mild closed head injury promotes a selective trigeminal hypernociception: implications for the acute emergence of post-traumatic headache.

Authors:  T Benromano; R Defrin; A H Ahn; J Zhao; C G Pick; D Levy
Journal:  Eur J Pain       Date:  2014-08-29       Impact factor: 3.931

10.  Prediction of headache severity (density and functional impact) after traumatic brain injury: A longitudinal multicenter study.

Authors:  William C Walker; Jennifer H Marwitz; Amber R Wilk; Jessica M Ketchum; Jeanne M Hoffman; Allen W Brown; Sylvia Lucas
Journal:  Cephalalgia       Date:  2013-04-10       Impact factor: 6.292

View more
  16 in total

Review 1.  From blast to bench: A translational mini-review of posttraumatic headache.

Authors:  Laura S Moye; Amynah A Pradhan
Journal:  J Neurosci Res       Date:  2017-02-02       Impact factor: 4.164

2.  Increased severity of closed head injury or repetitive subconcussive head impacts enhances post-traumatic headache-like behaviors in a rat model.

Authors:  Dara Bree; Jennifer Stratton; Dan Levy
Journal:  Cephalalgia       Date:  2020-06-29       Impact factor: 6.292

Review 3.  Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder.

Authors:  Kaitlin M Best; Marissa M Mojena; Gordon A Barr; Heath D Schmidt; Akiva S Cohen
Journal:  J Neurotrauma       Date:  2022-01       Impact factor: 4.869

4.  The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target.

Authors:  Laura S Moye; Madeline L Novack; Alycia F Tipton; Harish Krishnan; Subhash C Pandey; Amynah Aa Pradhan
Journal:  Cephalalgia       Date:  2018-05-17       Impact factor: 6.292

5.  Intact mast cell content during mild head injury is required for development of latent pain sensitization: implications for mechanisms underlying post-traumatic headache.

Authors:  Dara Bree; Dan Levy
Journal:  Pain       Date:  2019-05       Impact factor: 7.926

Review 6.  Dural Immune Cells, CGRP, and Migraine.

Authors:  Louis K Balcziak; Andrew F Russo
Journal:  Front Neurol       Date:  2022-03-31       Impact factor: 4.086

Review 7.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

Authors:  Stephen D Skaper; Laura Facci; Morena Zusso; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2018-03-21       Impact factor: 5.505

Review 8.  Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis.

Authors:  Duraisamy Kempuraj; Govindhasamy P Selvakumar; Ramasamy Thangavel; Mohammad E Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Shankar S Iyer; Sachin M Bhagavan; Swathi Beladakere-Ramaswamy; Asgar Zaheer
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

9.  Blast-induced brain injury in rats leads to transient vestibulomotor deficits and persistent orofacial pain.

Authors:  Paige E Studlack; Kaspar Keledjian; Tayyiaba Farooq; Titilola Akintola; Volodymyr Gerzanich; J Marc Simard; Asaf Keller
Journal:  Brain Inj       Date:  2018-10-22       Impact factor: 2.167

10.  Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.

Authors:  Carlo Caltagirone; Carlo Cisari; Carlo Schievano; Rosanna Di Paola; Marika Cordaro; Giuseppe Bruschetta; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Transl Stroke Res       Date:  2015-12-26       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.